Antibody Drugs

Antibody Drugs includes companies developing monoclonal antibodies or related antibody-based therapeutics. These assets are central to many oncology, immunology, and rare-disease franchises because they can offer target specificity and scalable biologic development paths.

Why watch Antibody Drugs

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Antibody Drugs news

The latest feed items from companies currently grouped under Antibody Drugs.

1. 01
   2026-07-14 12:00 EST

   PMNProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026

   Source: ProMIS Neurosciences

2. 02
   2026-07-13 07:00 EST

   GSKJemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

   Source: GSK plc

3. 03
   2026-07-10 11:00 EST

   GSKGSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population

   Source: GSK plc

4. 04
   2026-07-09 10:00 EST

   GSKRoy Jakobs to join GSK Board as Non-Executive Director

   Source: GSK plc

5. 05
   2026-07-09 03:08 EST

   IFRXPress Release

   Source: Inflarx NV

6. 06
   2026-07-09 03:08 EST

   IFRXPress Release

   Source: Inflarx NV

7. 07
   2026-07-09 03:08 EST

   IFRXPress Release

   Source: Inflarx NV

8. 08
   2026-07-09 03:08 EST

   IFRXPress Release

   Source: Inflarx NV

9. 09
   2026-07-09 03:08 EST

   IFRXPress Release

   Source: Inflarx NV

10. 10
    2026-06-25 20:05 EST

    REGNRegeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast

    Source: Regeneron Pharmaceuticals

11. 11
    2026-06-25 13:46 EST

    GSKGSK announces commencement of tender offer to acquire Nuvalent, Inc.

    Source: GSK plc

12. 12
    2026-06-25 13:46 EST

    REGNCemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

    Source: Regeneron Pharmaceuticals

13. 13
    2026-06-25 13:46 EST

    GSKUtebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

    Source: GSK plc

14. 14
    2026-06-25 13:46 EST

    GSKGSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome

    Source: GSK plc

15. 15
    2026-06-25 13:46 EST

    CRVSCorvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

    Source: Corvus Pharmaceuticals

16. 16
    2026-06-25 13:46 EST

    GSKGSK enters agreement to acquire Nuvalent, Inc.

    Source: GSK plc

17. 17
    2026-06-25 13:46 EST

    REGNRegeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

    Source: Regeneron Pharmaceuticals

18. 18
    2026-06-25 13:46 EST

    CTMXCytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

    Source: CytomX Therapeutics, Inc.

19. 19
    2026-06-25 13:46 EST

    REGNRegeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak

    Source: Regeneron Pharmaceuticals

20. 20
    2026-06-25 13:46 EST

    GSKBepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

    Source: GSK plc

Companies in Antibody Drugs

29 companies tagged with Antibody Drugs.

Frequently Asked Questions